Device Trial Radar · NCT03012841
STOP Persistent AF
Last checked: Nov 19, 2026Latest source record: Feb 13, 2025 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Completed
Enrollment
186
Actual
Start
Mar 2, 2017
Primary completion
Aug 13, 2019
Study completion Aug 13, 2019
Sponsor
- Lead sponsor
- Medtronic Cardiac Ablation SolutionsPublic (MDT)
- Sponsor type
- Industry
- First posted
- Jan 6, 2017
Design
- Study type
- Interventional
- Phase
- Not applicable (typical for device studies)
- Allocation
- Not applicable (single group)
- Model
- Single group
- Masking
- None
- Primary purpose
- Treatment
- FDA-regulated device
- Yes
- Who can join
- All sexes, from 18 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
To demonstrate safety and effectiveness of the Arctic Front Advance™ and Freezor MAX® Cardiac CryoAblation Catheters for the treatment of drug refractory recurrent symptomatic persistent atrial fibrillation (AF).
Conditions
- Atrial Fibrillation
Interventions
Arctic Front Advance Cardiac CryoAblation CatheterDevice
Cryoablation
Primary outcomes
What the sponsor says the trial is designed to measure.
- Percent of Subjects Free From Treatment Failure at 12 Months After the Pulmonary Vein Isolation (PVI) Ablation Procedure.Time frame: 12 Months
- Percent of Subjects Free From a Primary Safety Event at 12 Months After the Pulmonary Vein Isolation (PVI) Ablation Procedure.Time frame: 12 months
Locations
25 sites in 3 countries. Site status is shown where the registry gives one.
Banner-University Medical Center Phoenix
Phoenix, Arizona
Colorado Heart and Vascular
Lakewood, Colorado
Medical Center of the Rockies
Loveland, Colorado
22 more study sites with a free account
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.